{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T11:08:32Z","timestamp":1753182512404,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T00:00:00Z","timestamp":1540944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002387","name":"NCI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002387","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Egyptian National Cancer Institute"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jnci.2018.10.003","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T06:37:34Z","timestamp":1542868654000},"page":"139-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Combined cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as a treatment for recurrent epithelial ovarian cancer-National Cancer Institute experience"],"prefix":"10.1186","volume":"30","author":[{"given":"Mohamed Ibrahim","family":"Fahim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omaya Abdelhamid","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman Mohamed","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelmaksoud Mohamed","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed-Mostafa","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasha Mahmoud","family":"Allam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amr","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"9698","key":"10.1016\/j.jnci.2018.10.003_b0005","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(09)61338-6","article-title":"Ovarian cancer","volume":"374","author":"Hennessy","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jnci.2018.10.003_b0010","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ygyno.2004.07.033","article-title":"Teritary cytoreduction in patients with recurrent ovarian cancer","volume":"95","author":"Leitao","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"17","key":"10.1016\/j.jnci.2018.10.003_b0015","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a gynecologic oncology group study","volume":"21","author":"Ozols","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jnci.2018.10.003_b0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000355905","article-title":"Successes and limitations of targeted cancer therapy in ovarian cancer","volume":"41","author":"Damia","year":"2014","journal-title":"Prog Tumor Res"},{"issue":"3","key":"10.1016\/j.jnci.2018.10.003_b0025","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ygyno.2012.09.020","article-title":"cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: a case-control study on survival in patients with two year follow-up","volume":"127","author":"Fagotti","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.jnci.2018.10.003_b0030","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/jso.23688","article-title":"Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in recurrent ovarian cancer improve progression-disease survival especially in BRCA-positive patients- a case-control study","volume":"110","author":"Safra","year":"2014","journal-title":"J Surg Oncol"},{"issue":"5","key":"10.1016\/j.jnci.2018.10.003_b0035","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1245\/s10434-014-4157-9","article-title":"Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study","volume":"22","author":"Spiliotis","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.jnci.2018.10.003_b0040","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1080\/02656736.2017.1278631","article-title":"Progress in the management of primary and recurrent ovarian carcinomatosis with peritonectomy procedure and HIPEC in a high volume centre","volume":"33","author":"Arjona-Sanchez","year":"2017","journal-title":"Int J Hyperthermia"},{"issue":"2","key":"10.1016\/j.jnci.2018.10.003_b0045","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.tranon.2016.02.002","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat advanced\/recurrent epithelial ovarian cancer: results from a retrospective study on prospectively established database","volume":"9","author":"Sun","year":"2016","journal-title":"Transl Oncol"},{"issue":"4","key":"10.1016\/j.jnci.2018.10.003_b0050","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/IGC.0000000000000664","article-title":"Heated IntraPEritoneal Chemotherapy (HIPEC) for patients with recurrent ovarian cancer: a systematic literature review","volume":"26","author":"Hotouras","year":"2016","journal-title":"Int J Gynecol Cancer"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S111003621830061X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S111003621830061X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T09:40:32Z","timestamp":1558604432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S111003621830061X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S111003621830061X"],"URL":"https:\/\/doi.org\/10.1016\/j.jnci.2018.10.003","relation":{},"ISSN":["1110-0362"],"issn-type":[{"type":"print","value":"1110-0362"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as a treatment for recurrent epithelial ovarian cancer-National Cancer Institute experience","name":"articletitle","label":"Article Title"},{"value":"Journal of the Egyptian National Cancer Institute","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnci.2018.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 National Cancer Institute, Cairo University. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}